DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Albers FC, Licskai C, Chanez P. et al.
Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma.
Respir Med 2019;
159: 105806
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.